You are attempting to add a reference to this module that exists on another site in this group. This module may or may not support sharing across multiple sites - it doesn't explicitly state either way whether it does. If you are sure that it does, or if your intent is to test its ability to do so, then proceed with caution and be aware that certain functionality in the module - or even the entire module - may not function correctly in this configuration.
If you are confused by this message or are working on a site that cannot tolerate any breakage, you should click Cancel and contact the DotNetNuke Support Team.
The Medicines Quality Control and Surveillance Department is the sole ISO/IEC 17025 accredited pharmaceutical quality control laboratory in the Caribbean. As part of the Caribbean Public Health Agency, the laboratory analyses and verifies the adherence of medicines/ pharmaceuticals marketed in the Caribbean to international quality and safety standards.
We provide CARPHA Member States with an efficient, well equipped facility for essential monitoring of imported or locally manufactured drugs marketed in the region focusing on:
The Laboratory monitors medicinal quality in the Caribbean through the following substantive portfolio:
Conducting routine risk-based testing of medicines for market approval in collaboration with National Regulatory Authorities/ Ministries of Health within CMS.
POST MARKET SURVEILLANCE PROGRAMMEConducting a risk-based post market surveillance programme in partnership with National Regulatory Authorities/ Ministries of Health and CARPHA’s regulatory unit, the Caribbean Regulatory System (CRS). The laboratory evaluates the continual quality of medicines after approval for sale in the region. CMS can report suspected substandard, falsified medicines and/or adverse medicine reactions to a regional platform called VigiCarib for analysis and action, including testing by the laboratory on an emergent basis.
REGIONAL CAPACITY BUILDING Provide technical and quality assurance training to counterparts in national pharmaceutical quality control laboratories upon request, to aid with capacity building and strengthening of technical competence.
Learn more Post Market Surveillance
Learn more Medicines Quality Control
Learn more Caribbean Regulatory System
Medicinal quality is fundamental to the preservation of public health. This aligns with CARICOM’s strategic priority of advancing initiatives for health and wellness for improvement of quality of life in the Caribbean. From minor ailments to critical illnesses, patients and medical professionals rely on medicines for curative treatment and/or management. Through our risk-based testing and comprehensive post market surveillance programme and regional partnerships, the Medicines Quality Control and Surveillance Department is a key component in establishing regional confidence in medicines on the market by: